Close

Ratings by RBC Capital (Gregory Renza)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/18/2022 Provention Bio Inc. PRVB Maintain Sector Perform
(N/A)
 
 
  Details
11/8/2022 Xencor, Inc. XNCR Maintain Outperform
(N/A)
 
 
  Details
11/4/2022 Verastem VSTM Maintain Outperform
(N/A)
 
 
  Details
11/4/2022 Provention Bio Inc. PRVB Maintain Sector Perform
(N/A)
 
 
  Details
11/3/2022 Morphic Therapeutic MORF Maintain Outperform
(N/A)
 
 
  Details
11/3/2022 Acadia Pharmaceuticals ACAD Maintain Outperform
(N/A)
 
 
  Details
11/2/2022 Aptose Biosciences APTO Maintain Outperform
(N/A)
 
 
  Details
10/4/2022 Prometheus Biosciences Inc RXDX Maintain Outperform
(N/A)
 
 
  Details
9/30/2022 BELLUS Health Inc. BLU Maintain Outperform
(N/A)
 
 
  Details
8/12/2022 Prometheus Biosciences Inc RXDX Maintain Outperform
(N/A)
 
 
  Details
8/9/2022 Acadia Pharmaceuticals ACAD Maintain Outperform
(N/A)
 
 
  Details
8/9/2022 Global Blood Therapeutics GBT Downgrade Sector Perform
(Outperform)
63.84
(68.49)
7.28% Details
8/5/2022 Avalo Therapeutics Inc. AVTX Maintain Outperform
(N/A)
 
 
  Details
8/4/2022 Xencor, Inc. XNCR Maintain Outperform
(N/A)
 
 
  Details
8/4/2022 Morphic Therapeutic MORF Maintain Outperform
(N/A)
 
 
  Details
7/13/2022 BELLUS Health Inc. BLU Maintain Outperform
(N/A)
 
 
  Details
6/21/2022 Acadia Pharmaceuticals ACAD Maintain Outperform
(N/A)
 
 
  Details
6/15/2022 Acadia Pharmaceuticals ACAD Maintain Outperform
(N/A)
 
 
  Details
5/13/2022 Prometheus Biosciences Inc RXDX Maintain Outperform
(N/A)
 
 
  Details
5/10/2022 Aptose Biosciences APTO Maintain Outperform
(N/A)
 
 
  Details
5/6/2022 Xencor, Inc. XNCR Maintain Outperform
(N/A)
 
 
  Details
5/6/2022 Avalo Therapeutics Inc. AVTX Maintain Outperform
(N/A)
 
 
  Details
5/5/2022 Acadia Pharmaceuticals ACAD Maintain Outperform
(N/A)
 
 
  Details
4/18/2022 Nurix NRIX Maintain Outperform
(N/A)
 
 
  Details
4/14/2022 Verastem VSTM New Coverage Outperform
(N/A)
1.47
(0.39)
-73.47% Details
3/16/2022 Aprea APRE Maintain Sector Perform
(N/A)
 
 
  Details
3/15/2022 Spruce Biosciences, Inc. SPRB Maintain Outperform
(N/A)
 
 
  Details
3/3/2022 Avalo Therapeutics Inc. AVTX Maintain Outperform
(N/A)
 
 
  Details
3/2/2022 Inovio Pharmaceuticals INO Maintain Sector Perform
(N/A)
 
 
  Details
2/25/2022 Morphic Therapeutic MORF Maintain Outperform
(N/A)
 
 
  Details
12/21/2021 Acadia Pharmaceuticals ACAD Maintain Outperform
(N/A)
 
 
  Details
12/17/2021 BELLUS Health Inc. BLU Maintain Outperform
(N/A)
 
 
  Details
12/13/2021 Prometheus Biosciences Inc RXDX New Coverage Outperform
(N/A)
33.38
(44.73)
34% Details
11/12/2021 Gamida Cell Ltd. GMDA Maintain Outperform
(N/A)
 
 
  Details
11/5/2021 Global Blood Therapeutics GBT Maintain Outperform
(N/A)
 
 
  Details
11/1/2021 Inovio Pharmaceuticals INO Maintain Sector Perform
(N/A)
 
 
  Details
10/18/2021 BELLUS Health Inc. BLU Maintain Outperform
(N/A)
 
 
  Details
9/24/2021 Avalo Therapeutics Inc. AVTX New Coverage Outperform
(N/A)
2.46
(5.46)
121.95% Details
9/2/2021 Acadia Pharmaceuticals ACAD Maintain Outperform
(N/A)
 
 
  Details
8/13/2021 Aprea APRE Maintain Sector Perform
(N/A)
 
 
  Details
5/11/2021 Inovio Pharmaceuticals INO Maintain Sector Perform
(N/A)
 
 
  Details
5/7/2021 Provention Bio Inc. PRVB Maintain Sector Perform
(N/A)
 
 
  Details
5/7/2021 Aprea APRE Maintain Sector Perform
(N/A)
 
 
  Details
5/6/2021 Xencor, Inc. XNCR Maintain Outperform
(N/A)
 
 
  Details
5/6/2021 Global Blood Therapeutics GBT Maintain Outperform
(N/A)
 
 
  Details
4/9/2021 Provention Bio Inc. PRVB Downgrade Sector Perform
(Outperform)
9.74
(9.50)
-2.46% Details
3/17/2021 Aprea APRE Maintain Sector Perform
(Sector Perform)
 
 
  Details
3/10/2021 Gamida Cell Ltd. GMDA Maintain Outperform
(N/A)
 
 
  Details
3/9/2021 Acadia Pharmaceuticals ACAD Maintain Outperform
(N/A)
 
 
  Details
2/24/2021 Xencor, Inc. XNCR Maintain Outperform
(N/A)
 
 
  Details
2/2/2021 Morphic Therapeutic MORF Maintain Outperform
(N/A)
 
 
  Details
1/29/2021 BELLUS Health Inc. BLU New Coverage Outperform
(N/A)
3.13
(9.10)
190.73% Details
12/28/2020 Aprea APRE Downgrade Sector Perform
(Outperform)
25.09
(0.39)
-98.45% Details
12/15/2020 Gamida Cell Ltd. GMDA Maintain Outperform
(N/A)
 
 
  Details
12/3/2020 Global Blood Therapeutics GBT New Coverage Outperform
(N/A)
44.78
(63.84)
42.56% Details
11/16/2020 Inovio Pharmaceuticals INO Maintain Sector Perform
(N/A)
 
 
  Details
11/10/2020 Inovio Pharmaceuticals INO Maintain Sector Perform
(N/A)
 
 
  Details
11/3/2020 Spruce Biosciences, Inc. SPRB New Coverage Outperform
(N/A)
20.30
(1.09)
-94.63% Details
10/26/2020 Morphic Therapeutic MORF New Coverage Outperform
(N/A)
28.66
(27.52)
-3.98% Details
8/12/2020 Gamida Cell Ltd. GMDA Maintain Outperform
(N/A)
 
 
  Details
8/12/2020 Aprea APRE Maintain Outperform
(N/A)
 
 
  Details
8/11/2020 Inovio Pharmaceuticals INO Maintain Sector Perform
(N/A)
 
 
  Details
8/5/2020 Xencor, Inc. XNCR Maintain Outperform
(N/A)
 
 
  Details
8/5/2020 Aptose Biosciences APTO Maintain Outperform
(N/A)
 
 
  Details
6/4/2020 Provention Bio Inc. PRVB New Coverage Outperform
(N/A)
14.48
(9.50)
-34.39% Details
6/2/2020 Inovio Pharmaceuticals INO Maintain Sector Perform
(N/A)
 
 
  Details
6/2/2020 Iterum Therapeutics ITRM Downgrade Sector Perform
(Outperform)
4.21
(1.33)
-68.41% Details
5/15/2020 Iterum Therapeutics ITRM Maintain Outperform
(N/A)
 
 
  Details
5/8/2020 Xencor, Inc. XNCR Maintain Outperform
(N/A)
 
 
  Details
5/7/2020 Inovio Pharmaceuticals INO Maintain Sector Perform
(N/A)
 
 
  Details
5/6/2020 Aptose Biosciences APTO Maintain Outperform
(N/A)
 
 
  Details
4/23/2020 Portola Pharmaceuticals PTLA New Coverage Outperform
(N/A)
6.76
(18.03)
166.72% Details
3/13/2020 Iterum Therapeutics ITRM Maintain Outperform
(N/A)
 
 
  Details
3/13/2020 Inovio Pharmaceuticals INO Downgrade Sector Perform
(Outperform)
8.37
(2.01)
-75.99% Details
3/11/2020 Aptose Biosciences APTO Maintain Outperform
(N/A)
 
 
  Details
2/10/2020 Inovio Pharmaceuticals INO Maintain Outperform
(N/A)
 
 
  Details
1/30/2020 Xencor, Inc. XNCR New Coverage Outperform
(N/A)
33.79
(28.54)
-15.54% Details
1/23/2020 Inovio Pharmaceuticals INO Maintain Outperform
(N/A)
 
 
  Details
12/11/2019 Iterum Therapeutics ITRM Maintain Outperform
(N/A)
 
 
  Details
12/10/2019 ArQule ARQL Downgrade Sector Perform
(Outperform)
9.67
(20.00)
106.83% Details
11/14/2019 Gamida Cell Ltd. GMDA Maintain Outperform
(N/A)
 
 
  Details
10/28/2019 Aprea APRE New Coverage Outperform
(N/A)
25.59
(25.09)
-1.95% Details
10/9/2019 ArQule ARQL Maintain Outperform
(N/A)
 
 
  Details
8/15/2019 Iterum Therapeutics ITRM Maintain Outperform
(N/A)
 
 
  Details
6/19/2019 ArQule ARQL Maintain Outperform
(N/A)
 
 
  Details
5/15/2019 Iterum Therapeutics ITRM Maintain Outperform
(N/A)
 
 
  Details
5/10/2019 Inovio Pharmaceuticals INO Maintain Outperform
(N/A)
 
 
  Details
5/8/2019 Gamida Cell Ltd. GMDA Maintain Outperform
(N/A)
 
 
  Details
5/2/2019 ArQule ARQL Maintain Outperform
(N/A)
 
 
  Details
4/11/2019 ArQule ARQL New Coverage Outperform
(N/A)
5.43
(20.00)
268.32% Details
3/27/2019 Iterum Therapeutics ITRM Maintain Outperform
(N/A)
 
 
  Details
3/13/2019 Inovio Pharmaceuticals INO Maintain Outperform
(N/A)
 
 
  Details
3/1/2019 Aptose Biosciences APTO New Coverage Outperform
(N/A)
1.76
(0.70)
-60.23% Details
11/20/2018 Gamida Cell Ltd. GMDA New Coverage Outperform
(N/A)
9.60
(1.60)
-83.33% Details
11/15/2018 Iterum Therapeutics ITRM Maintain Outperform
(N/A)
 
 
  Details